1-20 of 36 results for subject:"BGI Group"
Librarians' tools
- Search time
- 0.229 seconds
- Solr query time
- 0.003 seconds
- Search query
- subject:"BGI Group"
- We searched for
- subject_t:"BGI Group" OR subject_t:"Beijing Genomics Institute" OR subject_t:BGI OR subject_ses:492209
Type
House
Session
Year
Department
Member
More
Primary member
Answering member
Legislative stage
Legislation
Subject
More
Publisher
To ask the Secretary of State for Health and Social Care, if he will exclude (a) BGI Group, (b) MGI Tech and (c) other state-linked genomics companies blacklisted by the United States from public sector health bodies.
To ask the Secretary of State for Health and Social Care, if he will exclude (a) BGI Group, (b) MGI Tech and (c) other state-linked genomics companies blacklisted by the United States from public sector health bodies.
The Government continues to review the evolving national security risks in the life sciences sector, including engaging with partners and allies, while ensuring that the United Kingdom is at the forefront of innovation.
The Procurement Act will come into force in 2025 and will include a Debarment Review Service, which aims to safeguard public procurement from suppliers deemed to pose a risk. As with all national security risks, there will be engagement with colleagues across Cabinet and Parliament to ensure we maintain a robust approach to managing these risks as they evolve.
To ask the Secretary of State for Health and Social Care, whether he has had discussions with (a) Cabinet colleagues, (b) Genomics England, (c) UK Biobank and (d) NIHR BioResource on (i) BGI Group, (ii) MGI Tech and (iii) other state-linked genomics companies blacklisted by the USA.
To ask the Secretary of State for Health and Social Care, whether he has had discussions with (a) Cabinet colleagues, (b) Genomics England, (c) UK Biobank and (d) NIHR BioResource on (i) BGI Group, (ii) MGI Tech and (iii) other state-linked genomics companies blacklisted by the USA.
Through the delivery of the UK Biological Security Strategy, the Government is committed to ensuring the United Kingdom is resilient to a spectrum of biological threats, as well as being a world leader in innovation. As part of this strategy, the Government is undertaking a programme of work to assess how we can minimise the risks from biological data to protect our burgeoning bioeconomy and build confidence in sharing personal data, to improve health outcomes in the UK and across the world.
Department officials are working closely with UK Biobank, Genomics England, and the National Institute for Health and Care Research Bioresource on this programme of work, and there will be continued engagement with my Cabinet colleagues.
To ask the Secretary of State for Defence, whether the BGI Group (a) has or (b) has ever had contracts with his Department.
To ask the Secretary of State for Defence, whether the BGI Group (a) has or (b) has ever had contracts with his Department.
The Ministry of Defence does not have, nor has ever had, contracts with the BGI Group.
To ask the Secretary of State for Science, Innovation and Technology, pursuant to the Answer of 26 February 2024 to Question 14260 on Genomics: China, whether the programme of work to assess risks from biological data will include a review of (a) BGI Group, (b) MGI Tech and (c) other...
To ask the Secretary of State for Science, Innovation and Technology, pursuant to the Answer of 26 February 2024 to Question 14260 on Genomics: China, whether the programme of work to assess risks from biological data will include a review of (a) BGI Group, (b) MGI Tech and (c) other...
Through the delivery of our Biological Security Strategy, the Government is committed ensuring the UK is resilient to a spectrum of biological threats, as well as being a world leader in innovation. As part of this Strategy, the Government is undertaking a programme of work to assess how we can minimise the risks from biological data to protect our burgeoning bioeconomy and build confidence in sharing personal data to improve health outcomes in the UK and across the world. This review covers the extent to which the UK shares data with certain companies.
Currently, organisations which hold sensitive biological data are subject to the UK General Data Protection Regulation (GDPR). In addition, organisations such as Genomics England, UK Biobank and NIHR BioResource actively consider national security in decision making about partnerships with companies overseas. These organisations consult with security personnel on a regular basis to ensure partnerships are aligned with our national security interests.
To ask the Secretary of State for Health and Social Care, what information her Department holds on the number of non-invasive pre-natal tests branded as NIFTY and manufactured by BGI Group have been sold in the UK.
To ask the Secretary of State for Health and Social Care, what information her Department holds on the number of non-invasive pre-natal tests branded as NIFTY and manufactured by BGI Group have been sold in the UK.
The Department and NHS England do not hold information on the sales within the United Kingdom of the non-invasive pre-natal tests branded as NIFTY, manufactured by BGI Group. The NHS Supply Chain, who manage the sourcing, delivery, and supply of healthcare products, services, and food for National Health Service trusts and healthcare organisations across England, develop procurement frameworks which enable NHS organisations to buy goods and services from suppliers. NHS Supply Chain has confirmed that non-invasive pre-natal tests branded as NIFTY and manufactured by BGI Group, are not on their procurement framework.
To ask the Secretary of State for Science, Innovation and Technology, with reference to the oral contribution of the Minister of State, Department for Science, Innovation and Technology, during the debate on Genomics and national security of 8 March 2023, Official Report column 120WH, what steps she is taking to...
To ask the Secretary of State for Science, Innovation and Technology, with reference to the oral contribution of the Minister of State, Department for Science, Innovation and Technology, during the debate on Genomics and national security of 8 March 2023, Official Report column 120WH, what steps she is taking to...
Organisations which hold sensitive biological data are subject to the UK General Data Protection Regulation (GDPR). In addition, organisations such as Genomics England, UK Biobank and NIHR BioResource actively consider national security in decision making about partnerships with companies overseas.
As part of the new UK Biological Security Strategy, the Government is undertaking a programme of work to assess how we can minimise the risks from biological data to protect our burgeoning bioeconomy, without stifling innovation, and build confidence in sharing personal data to improve health outcomes in the UK and across the world. The Office for Life Sciences has begun this work, in consultation with relevant Departments and Agencies across Government, and key partners such as Genomics England and UK Biobank.
To ask the Secretary of State for Science, Innovation and Technology, whether representatives of (a) BGI Group, (b) subsidiaries of BGI Group and (c) companies in which BGI Group has invested have been invited to attend the UK AI safety summit scheduled to take place in November 2023.
To ask the Secretary of State for Science, Innovation and Technology, whether representatives of (a) BGI Group, (b) subsidiaries of BGI Group and (c) companies in which BGI Group has invested have been invited to attend the UK AI safety summit scheduled to take place in November 2023.
To ensure the AI Safety Summit can achieve its objectives, it is necessary to have a small but international discussion at the event. This will limit the participants to around 100, including world leaders and companies at the cutting edge of frontier AI. The UK has actively considered national security in decision making to ensure that the partnerships and invitees are aligned with our National Security interests. Further information about invitees will be made available in due course.
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, whether he plans to raise with the Chinese Government the potential risks to UK health and genetic data of (a) BGI Group and (b) other Chinese genomics firms.
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, whether he plans to raise with the Chinese Government the potential risks to UK health and genetic data of (a) BGI Group and (b) other Chinese genomics firms.
We continually monitor threats to our data and will not hesitate to take action if necessary to protect our national security. We expect all firms to fully comply with UK privacy laws. Those which do not may be investigated and subject to enforcement action. We have also strengthened measures to prevent the transfer of assets or technology that could pose national security risks. This includes upgrading our export control regime and Military End Use Control and introducing the National Security and Investment Act. As part of the new UK Biological Security Strategy, the Government is undertaking a full programme of work to assess how we can minimise the risks from biological data to protect our burgeoning bioeconomy, without stifling innovation, and build confidence in sharing personal data to improve health outcomes in the UK and across the world.
To ask the Secretary of State for the Home Department, how many and what proportion of (a) scientists and (b) postgraduate students barred from working in the UK in 2023 on national security grounds are associated with BGI Group.
To ask the Secretary of State for the Home Department, how many and what proportion of (a) scientists and (b) postgraduate students barred from working in the UK in 2023 on national security grounds are associated with BGI Group.
We do not publicly comment on matters of national security.
To ask the Secretary of State for the Home Department, whether the National Protective Security Authority is taking steps to provide guidance to (a) businesses and (b) universities on dealing with BGI Group.
To ask the Secretary of State for the Home Department, whether the National Protective Security Authority is taking steps to provide guidance to (a) businesses and (b) universities on dealing with BGI Group.
The National Protective Security Authority, with the National Cyber Security Centre, have developed the Trusted Research campaign to help academia make the most of international collaborations, by informing them of the threat and helping them to make sensible decisions about research and research partners.
More recently they also developed the Secure Innovation campaign which is focused on helping new start-ups in the emerging and critical technology sectors to better protect themselves and, think carefully about their partners and investment.
We will continue to work with NPSA to support industry and academia.
To ask the Secretary of State for Science, Innovation and Technology, with reference to the oral contribution of the Minister of State on BGI Group in the debate on Genomics and National Security on 8 March 2023, Official Report, column 120WH, whether he plans to provide guidance to (a) business...
To ask the Secretary of State for Science, Innovation and Technology, with reference to the oral contribution of the Minister of State on BGI Group in the debate on Genomics and National Security on 8 March 2023, Official Report, column 120WH, whether he plans to provide guidance to (a) business...
The Government is committed to supporting UK businesses and academia to engage with any and all international collaborations that includes BGI in a way that reflects the UK’s values and takes account of national security concerns. We proactively engage with business and academia to make them aware of national security risks, including through the RCAT programme which supports universities with risk assessment.
The Government supports the academic sector to make informed decisions on international research collaboration through the Trusted Research campaign and supported Universities UK to develop guidelines, published in October 2020, to help universities tackle security risks related to international collaboration.
As part of the new UK Biological Security Strategy, which is due for publication in the coming months, the government is currently undertaking a full programme of work to assess how we can minimise the risks from biological data to protect our burgeoning bioeconomy, shape global norms and standards, without stifling innovation, and build confidence in sharing personal data to improve health outcomes in the UK and across the world.
To ask the Secretary of State for Science, Innovation and Technology, with reference to the US Department of Commerce adding BGI Tech Solutions (Hong Kong) to its export blacklist, if she will make an assessment of the potential impact of this company being awarded contracts by UK universities on national...
To ask the Secretary of State for Science, Innovation and Technology, with reference to the US Department of Commerce adding BGI Tech Solutions (Hong Kong) to its export blacklist, if she will make an assessment of the potential impact of this company being awarded contracts by UK universities on national...
The Government is committed to supporting UK businesses and academia to engage with any and all international collaborations that includes BGI in a way that reflects the UK’s values and takes account of national security concerns. We proactively engage with business and academia to make them aware of national security risks, including through the RCAT programme which supports universities with risk assessment.
The Government supports the academic sector to make informed decisions on international research collaboration through the Trusted Research campaign and supported Universities UK to develop guidelines, published in October 2020, to help universities tackle security risks related to international collaboration.
As part of the new UK Biological Security Strategy, which is due for publication in the coming months, the Government is currently undertaking a full programme of work to assess how we can minimise the risks from biological data to protect our burgeoning bioeconomy, shape global norms and standards, without stifling innovation, and build confidence in sharing personal data to improve health outcomes in the UK and across the world.
To ask His Majesty's Government, further to the remarks by the Minister of State, Department for Science, Innovation and Technology (HC Deb col 121WH) where he stated that Genomics England “was suffering several hack attacks from BGI each week”, what steps they are taking, if any, against that company; and what...
To ask His Majesty's Government, further to the remarks by the Minister of State, Department for Science, Innovation and Technology (HC Deb col 121WH) where he stated that Genomics England “was suffering several hack attacks from BGI each week”, what steps they are taking, if any, against that company; and what...
There is no recorded evidence of BGI attempting to hack Genomics England in 2014, and the Minister has amended the Hansard record accordingly. However, like most organisations they do receive regular attempts to access their systems, for which there are appropriate defences in place and no successful breaches have occurred.
Our current protocols allow Genomics England, UK Biobank and NIHR BioResource to consider national security in decision making about partnerships with companies overseas. These organisations have consulted with security personnel in the past to ensure partnerships are aligned with our national security interests.
As part of the new UK Biological Security Strategy, the Government is undertaking a full programme of work to assess how we can minimise the risks from biological data to protect our burgeoning bioeconomy, shape global norms and standards, without stifling innovation, and build confidence in sharing personal data to improve health outcomes in the UK and across the world.
We will conduct this work in conjunction with our partners at home, including Genomics England, the NHS and UK Biobank, and with our partners and allies around the world. The new UK Biological Security Strategy, to be published in the coming months, is part of the wider strategic direction of the Integrated Review, under which we are reviewing our policies on export controls and addressing potential vendors of concern across the economy.
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what discussions he has had with (a) Cabinet colleagues and (b) five eyes counterparts on the activities of BGI Group; and if the Government will make an assessment of the potential benefits of an investigation of that company.
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what discussions he has had with (a) Cabinet colleagues and (b) five eyes counterparts on the activities of BGI Group; and if the Government will make an assessment of the potential benefits of an investigation of that company.
We continually monitor threats to our data and will not hesitate to take action if necessary to protect our national security. We expect all firms to fully comply with UK privacy laws. Businesses which do not may be investigated and subject to enforcement action. We have also strengthened measures to prevent the transfer of assets or technology that could pose national security risks. This includes upgrading our export control regime and Military End Use Control and introducing the National Security and Investment Act.
Motion that this House has considered genomics and national security. Agreed to on question. Sitting suspended.
Motion that this House has considered genomics and national security. Agreed to on question. Sitting suspended.
It is a pleasure to serve under your chairmanship, Mr Davies. I thank the right hon. Member for Orkney and Shetland (Mr Carmichael) for bringing this important issue to the House. He and I both know how important the subject is and that the Chamber is not full because of...
It is a pleasure to serve under your chairmanship, Mr Davies. I thank the right hon. Member for Orkney and Shetland (Mr Carmichael) for bringing this important issue to the House. He and I both know how important the subject is and that the Chamber is not full because of...
I beg to move,
That this House has considered genomics and national security.
Alistair Campbell, of course, might be somebody who will wind up at some point. Notwithstanding that minor quibble, it is a pleasure to serve with you in the Chair, Mr Davies, and to bring what might be seen by...
I beg to move,
That this House has considered genomics and national security.
Alistair Campbell, of course, might be somebody who will wind up at some point. Notwithstanding that minor quibble, it is a pleasure to serve with you in the Chair, Mr Davies, and to bring what might be seen by...
I thank the right hon. Gentleman for securing this debate; he is right to underline the issue of risk. Not so long ago I read an article that highlighted the previous existing ties between UK universities and Chinese state-linked companies, about which the US National Security Commission on Artificial Intelligence...
I thank the right hon. Gentleman for securing this debate; he is right to underline the issue of risk. Not so long ago I read an article that highlighted the previous existing ties between UK universities and Chinese state-linked companies, about which the US National Security Commission on Artificial Intelligence...
Absolutely, and the question of the work in our universities and other research institutions is one to which I will turn in some detail later. I am grateful to the hon. Gentleman for giving me the opportunity to highlight its importance in this debate.
Consider, though, what happened in recent years...
Absolutely, and the question of the work in our universities and other research institutions is one to which I will turn in some detail later. I am grateful to the hon. Gentleman for giving me the opportunity to highlight its importance in this debate.
Consider, though, what happened in recent years...
I want to bring the Minister on to the point about BGI. I think we are aggressively agreeing with each other here, essentially because we are talking on parallel lines. Will he address the point about BGI and similar companies, and their need to comply or else be treated differently?
I want to bring the Minister on to the point about BGI. I think we are aggressively agreeing with each other here, essentially because we are talking on parallel lines. Will he address the point about BGI and similar companies, and their need to comply or else be treated differently?